HUTCHMED (China) Ltd (NASDAQ:HCM)
| 13.85 Delayed Data As of 3:59pm ET |  -0.29 / -2.05%Today’s Change | 8.40 Today|||52-Week Range 42.93 | -60.52% Year-to-Date |
Latest HCM News | Press Releases
No recent news for HUTCHMED (China) Ltd.
Today’s Trading
| Previous close | 14.14 |
| Today’s open | 13.75 |
| Day’s range | 13.71 - 14.06 |
| Volume | 9,755 |
| Average volume (3 months) | 551,468 |
| Market cap | $2.4B |
Data as of 3:59pm ET, 08/11/2022
Growth & Valuation
| Earnings growth (last year) | -36.32% |
| Earnings growth (this year) | -61.59% |
| Earnings growth (next 5 years) | -40.91% |
| Revenue growth (last year) | +56.21% |
| P/E ratio | NM |
| Price/Sales | 15.62 |
| Price/Book | 2.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XENEXenon Pharmaceutical... | -1.65 | -4.16% |
| ---- | ||
| SAGESAGE Therapeutics In... | -0.85 | -1.98% |
| GRFSGrifols SA | +0.00 | +0.06% |
Data as of 4:00pm ET, 08/11/2022
Financials
| Last reporting date | June 1, 2022 |
| EPS forecast (this quarter) | -$0.70 |
| Annual revenue (last year) | $356.1M |
| Annual profit (last year) | -$194.6M |
| Net profit margin | -54.66% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
